UBS Group AG - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 2 filers reported holding REGULUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$18,000
+125.0%
61,710
+157.6%
0.00%
Q4 2021$8,000
-42.9%
23,953
+20.5%
0.00%
Q3 2021$14,000
+250.0%
19,874
+610.3%
0.00%
Q4 2020$4,000
+300.0%
2,798
+210.2%
0.00%
Q2 2020$1,000
-85.7%
902
-89.0%
0.00%
Q4 2019$7,000
-41.7%
8,187
-51.2%
0.00%
Q3 2019$12,000
+500.0%
16,781
+752.3%
0.00%
Q1 2019$2,000
+100.0%
1,969
+110.6%
0.00%
Q4 2018$1,0009350.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 5,555,555$1,656,0000.43%
NEA Management Company, LLC 14,451,147$4,306,0000.12%
Sarissa Capital Management LP 1,851,851$552,0000.05%
Ikarian Capital, LLC 1,289,130$384,0000.05%
FEDERATED HERMES, INC. 29,048,265$8,656,0000.02%
WealthTrust Axiom LLC 68,000$20,0000.01%
All Terrain Financial Advisors, LLC 15,000$4,0000.00%
GYL FINANCIAL SYNERGIES, LLC 34,000$10,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 124,056$37,0000.00%
McGuire Investment Group, LLC 15,000$4,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders